Semaglutide is a game-changer in the weight loss industry
On May 30, Novo Nordisk announced that it was filing lawsuits against spas, clinics, pharmacies, and companies for "unlawful marketing" of compounded drugs, some of which allegedly did not contain semaglutide
GLP-1 Providers Mentioned In This Post Disclaimer: All providers listed in this comparison offer compounded GLP-1s
The advisory listed examples of seized products, including BPC-157, CJC-1295, DSIP, epitalon, GHK-Cu, HCG, ipamorelin, KPV, melanotan I and II, MOTS-c, NAD+, SS-31, TB-500 and retatrutide
Oral semaglutide works by regulating appetite and increasing feelings of fullness, helping patients manage their weight effectively and reducing the risks associated with obesity
August 15, 2025